, APAC
Photo by Miguel A Padrinan from Pexels

Manulife unveils new global head of gov’t relations

Her appointment will be effective on 16 October.

Manulife has appointed Maryscott Greenwood as the Global Head of Government Relations, effective from 16 October.

In this role, Greenwood will focus on advocating for and educating stakeholders on company interests at both national and international levels. Her efforts will aim to facilitate new business opportunities and enhance shareholder value. 

She will be a part of the company's Global Leadership Team, reporting to Manulife General Counsel James D. Gallagher.

ALSO READ: Manulife’s back in the black with C$1b net income in Q2

Greenwood served in various roles including corporate director, CEO, founder, and diplomat. 

She was previously the founding partner of Crestview Strategy US LLC, a government relations consultancy in Washington, D.C. She also held the position of managing director and group co-leader at Dentons U.S. LLP, where she led client strategy for the Canadian, U.S., and federal government affairs practices. 

Earlier in her career, Greenwood served as a Presidentially-appointed U.S. diplomat at the U.S. Embassy in Ottawa, Canada, and as chief of staff to the U.S. Ambassador.

 

Follow the link for more news on

Prudential, StanChart memperkuat 25 Tahun kemitraan bancassurance

Mereka memiliki kemitraan bancassurance terlama di Singapura dan Asia.

MSIG Asia dan RiskPoint mempertaruhkan asuransi energi terbarukan

Kawasan Asia-Pasifik berpotensi menarik investasi sebesar $3 triliun dalam pembangkitan listrik hingga 2033.

Kantor pusat Pru Life UK di Manila menerapkan kerja hibrida

Kantor ini memiliki area rekreasi dan kesehatan untuk membantu karyawan menyegarkan diri.

Etiqa meluncurkan produk asuransi takaful pertama di Singapura

Permintaan terhadap produk keuangan Islam dari Timur Tengah dan Asia Tenggara terus meningkat.

Perusahaan asuransi jiwa Singapura bidik pertumbuhan di 2025

Dorongan untuk solusi layanan kesehatan inovatif di tengah inflasi medis menjadi tantangan.